07:10 EDT Metsera (MTSR) receives unsolicted proposal from Novo Nordisk (NVO)
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTSR:
- Pfizer addresses proposal for Metsera
- Metsera’s MET233 Study: A Potential Game-Changer in Obesity Treatment
- Metsera’s New Phase 1 Study: A Potential Game-Changer in Obesity Treatment
- Metsera’s MET097 Study: A Potential Game-Changer in Obesity and Diabetes Treatment
- Metsera, Inc. Announces Special Meeting for Merger Vote with Pfizer